{"entity":{"id":"alliance-a011202","kind":"trial","name":"Alliance A011202: axillary treatment after residual positive sentinel nodes","aka":["A011202"],"tldr":"A011202 studies how to treat the axilla when sentinel nodes remain positive after chemotherapy. Both registry arms include radiation; this differs from the B-51 ypN0 question.","summary":"The retrieved registry describes an open-label randomised phase 3 comparison in cT1 to T3 N1 breast cancer with residual positive sentinel-node disease after neoadjuvant chemotherapy. The protocol requires a nodal metastasis greater than 0.2 millimetres; isolated tumour cells at or below that size are treated as N0i+. One arm includes completion level I/II axillary dissection and nodal radiation. The other includes radiation to the full axilla and nodal regions without that dissection.\n\nThe captured record lists 2,012 actual participants, active not recruiting status and estimated primary completion on 31 January 2031. Its primary measure is invasive breast cancer recurrence-free interval, with a stated follow-up timeframe up to eight years after radiation completion. The captured record supplies no efficacy estimate. Registry status is separate from a treatment result or availability at a local site.","status":"active","asOf":"2026-11-09","links":[{"label":"Exact ClinicalTrials.gov record and arms","url":"https://clinicaltrials.gov/study/NCT01901094"}],"tags":["education-audit","local-treatment"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":["sentinel-node","imrt-igrt"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["completion-surgery","regional-nodal-irradiation"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01901094","phase":"3","setting":"cT1 to T3 N1 breast cancer with positive sentinel-node disease after neoadjuvant chemotherapy: axillary dissection plus nodal radiation versus axillary plus nodal radiation without dissection","sponsor":"Alliance for Clinical Trials in Oncology","result":"The registry describes the comparison and follow-up, without an efficacy estimate.","started":"2014-02-24","startedType":"actual","enrolled":2012,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/alliance-a011202/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"technology":[{"id":"imrt-igrt","kind":"technology","name":"IMRT / IGRT (modern external beam)","route":"/technologies/imrt-igrt/"},{"id":"sentinel-node","kind":"technology","name":"Sentinel lymph node biopsy","route":"/technologies/sentinel-node/"}],"term":[{"id":"completion-surgery","kind":"term","name":"Completion surgery","route":"/terms/completion-surgery/"},{"id":"regional-nodal-irradiation","kind":"term","name":"Regional nodal irradiation in breast cancer","route":"/terms/regional-nodal-irradiation/"}]}}